Endoscopic Stricturoplasty (ES) of Hepaticojejunostomy Anastomotic Strictures (HAS): A Novel and Effective ERCP Technique Simon K. Lo, Shahab Mehdizadeh, Gary C. Chen HAS are difficult to treat endoscopically, surgically or transhepatically with a high recurrence rate. Technical failure and treatment complications are common. Aim: To assess the therapeutic efficacy of a new ES technique in the management of HAS. Methods: Retrospective review of ERCP for presumed or confirmed HAS. A pediatric variable stiffness colonoscope or push enteroscope was used except in post-Whipple cases where a therapeutic duodenoscope was favored. SKL introduced the method of ES in 1998 and performed all the procedures. When technically feasible, a guidewire was used to pass a standard sphincterotome to perform ES. Needle knife was used when guidewire access failed. Cutting was done in a 4-quadrant fashion for 4–5 mm each. Balloon dilation was then done with an 8 mm balloon. Stenting was not routinely carried out. Results: Data of 18 patients (mean 51 y.o., range 19–78) suspected of HAS was reviewed. Presentations: cholangitis (50%), abdominal pain (39%), itching (44%), abnormal liver enzymes (89%). Three groups of patients were identified: hepatojejunostomy for lap chole injuries (nZ10), Whipple’s (nZ4), and liver transplantation (nZ4). Symptom duration prior to treatment ranged from 1 month to 10 years (median 6 months). The bilioenteric anastamosis could not be reached in 4 (22%) patients. The remaining 14 patient underwent 18 ERCPs and all had technically successful ES. Needle knife was used in 4 patients. Five early cases included stent placement after sphincterotomy. Stone extraction was performed on 6 patients. 3 patients experienced 4 complications including 2 post-sphincterotomy bleeding (1-self limited; 1-treated endoscopically) and 2 cases of self-limited retroperitoneal air leak. The median follow up period was 15 months (range 0–50 months). Two patients had recurrences or did not improve despite ES and were referred for surgical therapy. Nine had successful ES without need for additional interventions in 20 months (range 4–50 months). 44% (8/18) of all patients remained asymptomatic at last follow up. Conclusions: ES is a novel technique to treat HAS. It is a single-session treatment and it does not require stenting that would mandate repeated procedures. Acquiring the skill is difficult as its prerequisite is successful passage through the long, tortuous afferent jejunal limb. It is reasonably safe and about half of the patients in this study enjoyed long term symptom-free living. T1284 Is Malnutrition a Cause of Post ERCP Cholangitis? Mohandas K. Mallath, Vivek Hande, Mrunal Shirodkar, Shaehta Mehta Background: Cholangitis is a serious complication of endoscopic biliary drainage. Malnutrition predisposes to infection in many clinical settings. This study was done to test a hypothesis that patients with malignant obstructive jaundice (MOJ) develop progressive malnutrition, which predisposes them for ERCP induced cholangitis. Methods: A prospective observational study design was used in the setting of a tertiary cancer center. Consecutive patients with MOJ undergoing endoscopic biliary drainage were eligible. Patients with cholangitis at presentation and those who had undergone ERCP, PTBD or biliary surgery were excluded. All patients were screened for malnutrition 1-2 days before the ERCP using subjective global assessment (SGA). Explanatory variables included bilirubin, albumin, anemia, leucocytosis, coagulopathy, and co-morbid diseases. All patients received antibiotic prophylaxis before ERCP. Other variables included duration of ERCP, proximal biliary obstruction, multiple instrumentation during ERCP, inadequate biliary drainage and type of biliary stent. All patients were followed up for 2 weeks for the development of cholangitis. Cholangitis was defined as the development of fever O100 F for more than 12 hours after an ERCP. Results: 77 patients (45 females, 32 males) aged 27 to 78 years (mean 51 years) were included. The cancer sites included gall bladder (37), pancreas (17), bile duct (13) and others (10). The malnutrition grade were SGA-A (7%), SGA-B (53%) and SGA-C (40%). 25 patients had leucocytosis and 14 had coagulopathy. ERCP was successful in 95%. 4 patients underwent PTBD. 26 (33.8%) patients developed cholangitis. It was mild in 80% and treated with oral antibiotics. 6 needed prolonged hospitalization and 4 needed early stent exchange. One severely malnourished patient developed duodenal perforation, septicemia and died. The cholangitis rates in mild, moderate and severely malnourished patients were 0%, 16% and 51% respectively (p!0.0001). Univariate analysis identified 5 explanatory variables to be associated with cholangitis: leucocytosis, severe malnutrition, proximal biliary obstruction, passage of multiple instruments and the use of plastic stents over metal stents by univariate analysis. In multivariate model, cholangitis was associated with malnutrition (OR 3.5, 95%CI 1.1–11.0) and multiple biliary instrumentation (OR 3.3, 95%CI 1.03– 10.7). Conclusions: Malnutrition is an independent risk factor for ERCP.
Read full abstract